Tag: Dr. Darryl Glover

Dr. Darryl Glover and Kayla Ashlee share simple solutions for your eyecare business to thrive on. Imagine having your optical’s data assessed by a...

The Diversity Advisory Board is part of the Transitions Optical sustainability plan focusing on carbon footprint and circularity, world sight light education, and inclusion and ethics. 

PINELLAS PARK, Fla., November 18, 2021 – Applications for the 2022 Transitions Change Agent and Transitions Student Ambassador programs are now being accepted online until November 30, 2021. Industry professionals interested in becoming a Transitions Change Agent can visit TransitionsPRO.com/ChangeAgent. Optometry and Opticianry students interested in becoming a Transitions Student Ambassador can visit http://transitionspro.com/StudentAmbassador. 

From supply chain issues, staffing shortages, and patient expectations for immediate, digital access to products and services, Dr. Deborah Weston talks about tools for...

This episode is brought to you in partnership with Essilor Do you prescribe specific brands when you write your patients’ glasses prescriptions? In a recent...

This podcast was sponsored by Transitions What’s next in light adaptive technology? We’re joined by Tara Hehr, Transitions Optical Key Account Manager for Independent Lens...

“We are redefining the color of the eyecare industry, 1% at a time,” states Dr. Essence Johnson as a goal for her work in Black Eyecare Perspective. “I’m passionately pursuing my purpose,” she shares, and joining the Transitions Optical Diversity Advisory Board was a natural fit. The Diversity Advisory Board is a collection of doctors, patient consumers, and industry professionals that help better understand and execute on where the eyecare industry can make actionable change. 

Shawn Lessard, founder of Modern Optician, shares his journey into opticianry, from training to becoming a modern optician. Learn about the exciting opportunities in eye care and how you can pursue a career in opticianry.

Treating dry eye has significant hurdles - chief among them being that many patients experience minimal or limited relief even after treatment. We're joined...